Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The norepinephrine transporter (NET), also known as the noradrenaline transporter (NAT), is a membrane protein responsible for the reuptake of synaptically released norepinephrine (NE) into presynaptic noradrenergic neurons. This process serves as the primary mechanism for terminating noradrenergic signaling. NET is a member of the solute carrier family 6 (SLC6A2) and its function is regulated by post-translational modifications and other cellular signaling events. Inhibition of NET is a therapeutic strategy for depression and ADHD.
Inhibition of norepinephrine reuptake, leading to increased synaptic norepinephrine levels.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Norepinephrine Transporter (NET).